Diabetes 54:34273434 Rizzo M, Rizvi AA, Patti AM, Nikolic D, Giglio RV, Castellino G et al (2016) Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study
Yes, many state Medicaid programs cover older, less expensive weight loss medications even when they do not cover GLP-1 shots
Novo Nordisk the company behind Ozempic, Wegovy and Rybelsus reported $31.1 billion in revenue from the medications in 2024, up from $11.9 billion in 2022
Focusing on low-fat, sodium-free, and unprocessed foods, as well as engaging in physical activity, is key to achieving weight loss goals
However, hormone therapy, like other non-surgical treatments, is only effective while it is being used